Luke Bryden, DPhil; Ana Todorovic, PhD; Panagiota Kontari, PhD; David Newton, BSc; Benjamin Fell, DPhil; Akrivia Health, Oxford, England, United Kingdom There is a need for further understanding of the underlying neurobiology, environmental factors, psychological mechanisms, and social determinants involved…
Everywhere we turn, we hear about AI. The benefits, the pitfalls, and how we can manage its use effectively, without AI damaging our society. To help us understand more about AI and what it has to offer the healthcare research…
Hello. Thank you for joining me today. My name is Tina Marshall and this is Precision Neuroscience Reimagined. I’m joined today by Max Taquet, who is an academic clinical fellow from Oxford. And today we’re going to be talking about…
In the latest episode of Precision Neuroscience Reimagined, Head of Governance, Ethics, and Patient Participation at Akrivia Health, Simon Pillinger, joined Tina to discuss how we can all help to mitigate and change the trajectory of research, covering the difference…
We are pleased to introduce the podcast series, Precision Neuroscience Reimaged: By Industry, for* Industry. In the first episode of Precision Neuroscience Reimagined, Jane Twitchen, Head, Clinical Trial Accelerator Unit & Senior Director, Global Clinical Operations, and Sarah Deeley, Senior…
As a part of the DPHARM 6-6 Analytics and Data for Patient Engagement, we discussed the challenges in bringing drugs to market and reviewed how we believe data can be used successfully to support drug discovery and development within mental…
Mike Denis, CEO of Akrivia Health, discusses real world data and how this can help us understand more about mental health disorders, enabling targeted precision medicine. The picture of mental health diagnosis today: Mental health problems account for 13% of…
